Literature DB >> 3650022

Correlation of enzyme-linked immunosorbent assays for serum human immunodeficiency virus antigen and antibodies to recombinant viral proteins with subsequent clinical outcomes in a cohort of asymptomatic homosexual men.

K H Mayer, L A Falk, D A Paul, G J Dawson, A M Stoddard, J McCusker, S P Saltzman, M W Moon, R Ferriani, J E Groopman.   

Abstract

A cohort of asymptomatic homosexual men at a Boston community health center was screened for the presence of human immunodeficiency virus (HIV) serum antigen and antibodies to recombinant proteins containing portions of the envelope and the gag (core) gene products. Of 196 asymptomatic men screened, 149 were antigen-negative/antibody-negative, 41 were antigen-negative/antibody-positive, and six were antigen-positive/antibody-positive. All three men in whom the acquired immune deficiency syndrome (AIDS) developed over the next year were antigen-positive at enrollment. Although a larger portion of the men who were antigen-positive and did not demonstrate progression to AIDS after one year had thrush, zoster, or generalized lymphadenopathy, the associations were not statistically significant. Whereas all of the seropositive men had antibody to viral envelope antigens, about a quarter did not have detectable antibodies to recombinant core antigens. However, all of these men had detectable antibody to core antigens by Western blot. Titers to recombinant core and envelope antigens tended to be lower in the men with AIDS. HIV-infected persons who are more likely to have enhanced immuno-compromise may be identified by these newer tests, but further longitudinal studies will be necessary to fully understand their prognostic value.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3650022     DOI: 10.1016/0002-9343(87)90686-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

1.  New sensitive and specific assay for human immunodeficiency virus antibodies using labeled recombinant fusion protein and time-resolved fluoroimmunoassay.

Authors:  H Siitari; P Turunen; J Schrimsher; M Nunn
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

2.  Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genes.

Authors:  V L Ng; C S Chiang; C Debouck; M S McGrath; T H Grove; J Mills
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

Review 3.  Antigen detection for human immunodeficiency virus.

Authors:  D J Harry; M B Jennings; J Yee; J R Carlson
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

4.  Association of human immunodeficiency virus (HIV) p24 antigenemia with decrease in CD4+ lymphocytes and onset of acquired immunodeficiency syndrome during the early phase of HIV infection.

Authors:  C Rinaldo; L Kingsley; J Neumann; D Reed; P Gupta; D Lyter
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

5.  Monitoring human immunodeficiency virus type 1-infected patients by ratio of antibodies to gp41 and p24.

Authors:  G Schmidt; K Amiraian; H Frey; J Wethers; R W Stevens; D S Berns
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

6.  Effects of HIV antibody test knowledge on subsequent sexual behaviors in a cohort of homosexually active men.

Authors:  J McCusker; A M Stoddard; K H Mayer; J Zapka; C Morrison; S P Saltzman
Journal:  Am J Public Health       Date:  1988-04       Impact factor: 9.308

7.  Predictive value of the presence of P24 antigen in persons with antibodies to human immunodeficiency virus in Spain.

Authors:  M Leal; J A Pineda; E J Calderón; C Rey; E Lissen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-03       Impact factor: 3.267

8.  Blind comparison of Abbott and Dupont HIV antigen ELISA tests for detecting antigenaemia in asymptomatic human immunodeficiency virus antibody positive homosexual men.

Authors:  D C Shanson; K E Brown; S Goonesekera; B Gazzard; A R Coates
Journal:  J Clin Pathol       Date:  1990-05       Impact factor: 3.411

9.  An Accurate Confirmation of Human Immunodeficiency Virus Type 1 (HIV-1) and 2 (HIV-2) Infections with a Dot blot assay Using Recombinant p24, gp41, gp120 and gp36 Antigens.

Authors:  Mehrdad Ravanshad; Farzaneh Sabahi; Fereidoun Mahboudi; Mohammad Hassan Roostaee; Ramin Sarami Forooshani; Anoshiravan Kazemnejad
Journal:  Int J Med Sci       Date:  2004-10-15       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.